en.Wedoany.com Reported - Recently, Mykor, a biotechnology company based in Bristol, UK, announced the completion of a new funding round of £4 million (approximately RMB 37 million). The round was co-led by Clean Growth Fund and The FSE Group, with participation from the British Business Bank's South West Investment Fund, Green Angel Ventures, and Innovate UK. To date, the company's total funding has reached £7.5 million (approximately RMB 69 million). Meanwhile, Mykor disclosed that it has signed commercial agreements worth over £338 million (approximately RMB 3.1 billion). The new funding will be primarily used to expand production capacity, advance product development, and enter the European market.
Founded in 2021, Mykor is a biotechnology company focused on low-carbon building materials. Its core technology platform converts industrial and agricultural waste into low-carbon biomaterials using proprietary engineered mycelium strains, green chemical additives, and a closed-loop biomanufacturing process. The company's CEO, Olivia Page, and COO, Valentina Dipietro, are both co-founders.
Mykor's first commercial product, MykoSIP, is a prefabricated partition wall system designed to replace or supplement traditional high-carbon materials. The product has passed rigorous fire safety, durability, and sound insulation tests, and also offers advantages in water and electricity consumption. According to the company, its products can help developers and contractors significantly reduce the embodied carbon of projects. The global construction industry accounts for approximately 39% of total global emissions, with about 11% coming from embodied carbon in building materials and another 28% from operational energy use. Meanwhile, building regulations in Europe and the UK are increasingly demanding low-carbon materials.
Mykor stated that it is not limited to being a material manufacturer; it also offers a scalable technology platform that allows manufacturing partners and contractors to integrate low-carbon biomaterials directly into existing supply chains and production facilities without major modifications to production lines. A partner at Clean Growth Fund UK commented: "Mykor's engineering biology platform will help decarbonize the building materials industry, effectively reducing greenhouse gas emissions across the entire value chain." A fund manager at The FSE Group noted that the company has secured substantial commercial agreements from large construction clients. As it expands production capacity and product lines, Mykor is accelerating the expansion of its biomanufacturing technology into key European markets.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
